J
James P. Stevenson
Researcher at Cleveland Clinic
Publications - 144
Citations - 9772
James P. Stevenson is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Lung cancer & Pembrolizumab. The author has an hindex of 41, co-authored 132 publications receiving 7719 citations. Previous affiliations of James P. Stevenson include Mayo Clinic & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer,Shirish M. Gadgeel,Hossein Borghaei,Vassiliki A. Papadimitrakopoulou,Amita Patnaik,Steven Francis Powell,Ryan D. Gentzler,Renato Martins,James P. Stevenson,Shadia I. Jalal,Amit Panwalkar,James Chih-Hsin Yang,Matthew A. Gubens,Lecia V. Sequist,Mark M. Awad,Joseph Fiore,Yang Ge,Harry Raftopoulos,Leena Gandhi,Leena Gandhi +19 more
TL;DR: This trial assessed whether the addition of pembrolizumab to platinum-doublet chemotherapy improves efficacy in patients with advanced non-squamous NSCLC, and the proportion of patients who achieved an objective response.
Journal ArticleDOI
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology
David S. Ettinger,Douglas E. Wood,Dara L. Aisner,Wallace Akerley,Jessica Bauman,Lucian R. Chirieac,Thomas A. D'Amico,Malcolm M. DeCamp,Thomas J. Dilling,Michael C. Dobelbower,Robert C. Doebele,Ramaswamy Govindan,Matthew A. Gubens,Mark Hennon,Leora Horn,Ritsuko Komaki,Rudy P. Lackner,Michael Lanuti,Ticiana A. Leal,Leah J. Leisch,Rogerio Lilenbaum,Jules Lin,Billy W. Loo,Renato Martins,Gregory A. Otterson,Karen L. Reckamp,Gregory J. Riely,Steven E. Schild,Theresa A. Shapiro,James P. Stevenson,Scott J. Swanson,Kurt Tauer,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +34 more
TL;DR: This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastasis disease.
Journal ArticleDOI
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger,David S. Ettinger,Douglas E. Wood,Douglas E. Wood,Dara L. Aisner,Wallace Akerley,Wallace Akerley,Jessica Bauman,Jessica Bauman,Ankit Bharat,Ankit Bharat,Debora S. Bruno,Debora S. Bruno,Joe Y. Chang,Joe Y. Chang,Lucian R. Chirieac,Thomas A. D'Amico,Thomas J. Dilling,Thomas J. Dilling,Jonathan E. Dowell,Scott N. Gettinger,Matthew A. Gubens,Aparna Hegde,Mark Hennon,Mark Hennon,Rudy P. Lackner,Michael Lanuti,Michael Lanuti,Ticiana A. Leal,Ticiana A. Leal,Jules Lin,Jules Lin,Billy W. Loo,Christine M. Lovly,Christine M. Lovly,Renato Martins,Renato Martins,Erminia Massarelli,Erminia Massarelli,Daniel Morgensztern,Daniel Morgensztern,Thomas Ng,Thomas Ng,Gregory A. Otterson,Gregory A. Otterson,Sandip P. Patel,Sandip P. Patel,Gregory J. Riely,Gregory J. Riely,Steven E. Schild,Steven E. Schild,Theresa A. Shapiro,Theresa A. Shapiro,Aditi P. Singh,Aditi P. Singh,James P. Stevenson,James P. Stevenson,Alda Tam,Alda Tam,Jane Yanagawa,Jane Yanagawa,Stephen C. Yang,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +64 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC as mentioned in this paper.
Journal ArticleDOI
Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines
David S. Ettinger,Douglas E. Wood,Charu Aggarwal,Dara L. Aisner,Wallace Akerley,Jessica Bauman,Ankit Bharat,Debora S. Bruno,Joe Y. Chang,Lucian R. Chirieac,Thomas A. D'Amico,Thomas J. Dilling,Michael C. Dobelbower,Scott N. Gettinger,Ramaswamy Govindan,Matthew A. Gubens,Mark Hennon,Leora Horn,Rudy P. Lackner,Michael Lanuti,Ticiana A. Leal,Jules Lin,Billy W. Loo,Renato Martins,Gregory A. Otterson,Sandip Pravin Patel,Karen L. Reckamp,Gregory J. Riely,Steven E. Schild,Theresa A. Shapiro,James P. Stevenson,Scott J. Swanson,Kurt Tauer,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +35 more
TL;DR: The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) as discussed by the authors address all aspects of management for NSCLC, focusing on recent updates in immunotherapy.
Journal ArticleDOI
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
David S. Ettinger,Dara L. Aisner,Douglas E. Wood,Wallace Akerley,Jessica Bauman,Joe Y. Chang,Lucian R. Chirieac,Thomas A. D'Amico,Thomas J. Dilling,Michael C. Dobelbower,Ramaswamy Govindan,Matthew A. Gubens,Mark Hennon,Leora Horn,Rudy P. Lackner,Michael Lanuti,Ticiana A. Leal,Rogerio Lilenbaum,Jules Lin,Billy W. Loo,Renato G. Martins,Gregory A. Otterson,Sandip Pravin Patel,Karen L. Reckamp,Gregory J. Riely,Steven E. Schild,Theresa A. Shapiro,James P. Stevenson,Scott J. Swanson,Kurt Tauer,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +32 more
TL;DR: The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC and for the 2018 update, a new section on biomarkers was added.